"糖尿病、甲状腺の専門医 糖尿病、甲状腺疾患などホルモンが関わる内科の病気を10名の専門医がカバーするクリニック。 JR三鷹駅とはロータリーデッキで繋がっており、徒歩1分もかからずに来院頂くことが出来ます。"

During the past decade, Kanno Naika conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kanno Naika" are "Diabetes Mellitus" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Endocrine System Diseases" (1 trials), "Glucose Metabolism Disorders" (1 trials) and "Hypoglycemic Agents" (1 trials). Many other conditions were trialed in "Kanno Naika" in a lesser frequency.

Most popular intervention types in "Kanno Naika" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alpha-Glucosidase Inhibitors (α-GI)" (1 trials), "Biguanide (BG)" (1 trials), "Dulaglutide" (1 trials), "Glinides (GLN)" (1 trials) and "Oral antihyperglycemic medication (OAM)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kanno Naika" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kanno Naika". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kanno Naika, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kanno Naika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".